A research group led by Associate Professor Tetsuya Muramoto from the Faculty of Science, Toho University, has established a ...
CRISPR Therapeutics is the first company to secure an FDA approval of a gene-editing drug. That drug's underlying science, however, could be used to create treatments for any number of genetically ...
A caffeine-triggered switch that turns CRISPR gene editing on and off inside cells could one day improve cancer therapy.
In the wake of the germline editing controversy, when Chinese scientist He Jianku illegally edited the embryos of human twins ...
A version of this Priestley Medal address will be presented at the American Chemical Society Spring 2026 meeting ...
A baby boy with a devastating genetic disease is thriving after becoming the first known person to receive a bespoke, CRISPR therapy-for-one, designed to correct his specific disease-causing mutation.
New Early Access Express License provides streamlined, affordable access to foundational CRISPR/Cas9 intellectual property to ...
Morning Overview on MSN
Gene editing advances raise real prospects for future DNA upgrades
The U.S. Food and Drug Administration approved the first cell-based gene therapies for sickle cell disease, including the first-ever treatment built on CRISPR/Cas9 technology. That decision moved gene ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果